PTK2 and prostate carcinoma: In a study of prostate cancer, activation of PTK6 in the plasma membrane was found to increase phosphorylation and to activate AKT,p130Cas and FAK, thereby promoting cancer cell proliferation, survival, migration, and epithelial-mesenchymal cell transformation [11].